219 antihypertensives suspended in sales due to ‘containing impurities’
The Ministry Food and Drug Safety(Minister Young-Jin Ryu, MFDS) will take actions of temporarily suspending sales, manufacturing and importation of all the products which used ‘Valsartan,’ an active pharmaceutical ingredient for the treatment of hypertension, as the European Medicines Agency was ...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.